Citation: H. Bier et al., ANTI-(EPIDERMAL GROWTH-FACTOR) RECEPTOR MONOCLONAL-ANTIBODIES FOR THEINDUCTION OF ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY AGAINST SQUAMOUS-CELL CARCINOMA LINES OF THE HEAD AND NECK, Cancer immunology and immunotherapy, 46(3), 1998, pp. 167-173
Authors:
HOFFMANN T
HAFNER D
BALLO H
HAAS I
BIER H
Citation: T. Hoffmann et al., ANTITUMOR-ACTIVITY OF ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR MONOCLONAL-ANTIBODIES AND CISPLATIN IN 10 HUMAN HEAD AND NECK SQUAMOUS-CELL CARCINOMA LINES, Anticancer research, 17(6D), 1997, pp. 4419-4425
Citation: H. Bier et al., CHEMOSENSITIVITY OF HEAD AND NECK SQUAMOUS CARCINOMA CELL-LINES IS NOT PRIMARILY CORRELATED WITH GLUTATHIONE LEVEL BUT IS MODIFIED BY GLUTATHIONE DEPLETION, Journal of cancer research and clinical oncology, 122(11), 1996, pp. 653-658
Citation: H. Bier et al., DOSE-DEPENDENT ACCESS OF MURINE ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR MONOCLONAL-ANTIBODY TO TUMOR-CELLS IN PATIENTS WITH ADVANCED LARYNGEALAND HYPOPHARYNGEAL CARCINOMA, European archives of oto-rhino-laryngology, 252(7), 1995, pp. 433-439
Citation: P. Koldovsky et al., IMMUNOHISTOCHEMICAL EXAMINATION OF 11 CELL-LINES DERIVED FROM HUMAN HEAD AND NECK SQUAMOUS-CELL CARCINOMAS, THEIR RECURRENCES OR METASTASES, European archives of oto-rhino-laryngology, 252(6), 1995, pp. 359-365
Citation: I. Haas et al., MORPHOLOGICAL AND HISTOLOGICAL STUDIES ON ORGAN-CULTURES OF HUMAN TRACHEAL BIOPSIES, Laryngo-, Rhino-, Otologie, 74(6), 1995, pp. 380-384
Citation: I. Haas et al., IMMUNOHISTOCHEMICAL ANALYSIS OF ADVANCED LARYNGEAL AND HYPOPHARYNGEALCARCINOMAS 3 DAYS AFTER APPLICATION OF MONOCLONAL-ANTIBODY AGAINST EPIDERMAL GROWTH-FACTOR RECEPTOR, Laryngo-, Rhino-, Otologie, 73(12), 1994, pp. 626-630
Authors:
MATTIJSSEN V
DEMULDER PH
DEGRAEFF A
HUPPERETS PS
JOOSTEN F
RUITER DJ
BIER H
PALMER PA
VANDENBROEK P
Citation: V. Mattijssen et al., INTRATUMORAL PEG-INTERLEUKIN-2 THERAPY IN PATIENTS WITH LOCOREGIONALLY RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA, Annals of oncology, 5(10), 1994, pp. 957-960
Citation: H. Bier et al., REGIONAL LOW-DOSE INTERLEUKIN-2 IMMUNOTHERAPY OF LYMPH-NODE MICROMETASTASIS IN A GUINEA-PIG TUMOR-MODEL, ORL, 56(2), 1994, pp. 96-100
Citation: H. Bier, CANCER-EPIDEMIOLOGY - CHANGES IN INCIDENC E OF MALIGNANT HEAD AND NECK TUMORS, HNO. Hals-, Nasen-, Ohrenarzte, 42(7), 1994, pp. 390-392
Citation: H. Bier, GROWTH-FACTORS AND CANCER - IMPORTANT INS IGHTS INTO THE REGULATION OF THE MALIGNANT PHENOTYPE, HNO. Hals-, Nasen-, Ohrenarzte, 42(3), 1994, pp. 145-146
Citation: H. Bier, CHEMOTHERAPEUTIC DRUG-RESISTANCE IN THE MANAGEMENT OF HEAD AND NECK-CANCER, European archives of oto-rhino-laryngology, 250(4), 1993, pp. 200-208
Citation: M. Furll et al., HORMONAL REACTIONS IN FATTENING BULLS AND COWS DURING A 3-WEEK BUTYRIC-ACID LOAD, Berliner und Munchener Tierarztliche Wochenschrift, 106(11), 1993, pp. 364-370